Y-90 SIRT

yttrium-90 selective internal radiation therapy

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Y-90 SIRT, covering 2025-01-28 to 2026-02-18. Get the full timeline:

Most recent: Clinical Trial Update: Durvalumab and Tremelimumab in Combination With Y-90 SIRT for Intermediate Stage HCC [Phase 2]